Delivery Order SPE2DR25D1120-SPE2DR26FZ2RT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,019.16 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This non-set-aside, competitively awarded contract employs firm fixed pricing and was executed on April 24, 2025, with an ultimate completion date of April 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,839.58 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of December 22, 2025, and represents a single delivery order under AmerisourceBergen's larger federal contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,095.09 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials, with an ultimate completion date of July 21, 2025. This non-set-aside contract employs firm fixed pricing and represents a discrete purchase order under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Phenobarbital 130 mg/ml in vial form, with a contract ceiling value of $2,611.73 and an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/mL vials valued at $2,123.64 under a firm fixed price contract. The award was made on November 17, 2025, with an ultimate completion date of November 18, 2025, and is classified as a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,268.00 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 65 mg/mL vials. The contract, executed on December 18, 2025, with an ultimate completion date of December 19, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a $3,837.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Phenobarbital 65 mg/ml vial on December 31, 2025, with an ultimate completion date of January 2, 2026. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $6,483.54 delivery order to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/ml vial on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This...
- The Defense Logistics Agency awarded a $3,410.16 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Phenobarbital 130 mg/mL in vial form. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition for the award. This delivery order is...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials with a ceiling value of $2,522.26. This firm fixed-price delivery order was competitively awarded without set-aside designations and is scheduled for completion by January 5, 2026. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, serving federal medical procurement needs across the military and veteran healthcare systems....
- SPE2DR25D1120Indefinite Delivery Contract
- SPE2DR25D1120-SPE2DR26FZ2RTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,837.60 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 65 mg/mL vials. This competitively awarded, non-set-aside delivery order was executed on January 2, 2026, with an ultimate completion date of January 5, 2026. The contract utilizes firm fixed price terms and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. As a prime vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen maintains a comprehensive portfolio of pharmaceutical products and medical supplies supporting military healthcare systems and other federal medical procurement needs. The Phenobarbital delivery supports the broad therapeutic coverage provided through this umbrella contract, which encompasses specialty medications, vaccines, syringes, vials, and other critical medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 1/1/26 |